Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Allergan, Inc. (AGN) Investment Propels Bill Ackman To The Top Of Hedge Funds Rankings

Hedge funds had a horrendous year in 2014 seen by more than 461 being shut down with only 2% being able to make substantial returns to investors.  Despite the horrendous run, activist investor Bill Ackman of Pershing Square managed to come up on top having bet big on Allergan, Inc. (NYSE:AGN) according to Bloomberg’s Betty Liu.

Bill Ackman, Pershing Square, BMW AG, the City, Canary Wharf, London, China, subsidy, Jonathan Ferro,

Ackman now sits at the top of the hedge fund world having seen his investments in Botox maker Allergan, Inc. (NYSE:AGN) pay up with a 33% return. The return did not come that easily as Ackman was entangled in a bitter tussle with Allergan over a potential merger with Valeant Pharmaceuticals Intl Inc. (NYSE:VRX). Bloomberg’, Katrina Brooker, notes that Ackman year was full of drama as he sought to come up on top in terms of returns.

“Allergan, Inc. (NYSE:AGN) CEO David Pyott played it in such an amazing way that you sought of felt like it was a battle of two equals, and they both ended up winning. In the end and that was just the strangest twist in November when Allergan escaped Valeant Pharmaceuticals Intl Inc. (NYSE:VRX)’s Perishing Square bid,” said Mrs. Brooker.

Ackman has not had the smoothest of rides in the hedge fund space having seen his long position in J C Penney Company Inc. (NYSE:JCP) as well as a short position in Herbalife Ltd. (NYSE:HLF) turn out disastrous resulting in millions of dollars in losses. Allergan, Inc. (NYSE:AGN) seems to have put Ackman’s woes in the market to rest with the acquisition of a further 10% stake in the company  turning out to be one of the best moves in 2014.

Brooker believes Ackman acquiring a 10% stake in the Botox maker was a kind of a provocative deal considering he was entangled in a bitter tussle over a merger with Valeant Pharmaceuticals Intl Inc. (NYSE:VRX).

“The analysts that I talked to remained shocked just as to how the deal came about. There are these questions about Pershing Square Valeant Pharmaceuticals Intl Inc. (NYSE:VRX) how they bought up shares of Allergan, Inc. (NYSE:AGN) prior to the deal announcement,” said Mrs. Brooker.

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks
Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.